Donald Hayden

Donald Hayden

Director Ejecutivo en
WindMIL Therapeutics, Inc.
.
70 años
Health Technology
Consumer Services
Consumer Non-Durables

Perfil

Donald J.
Hayden
is currently the Chairman & Chief Executive Officer at WindMIL Therapeutics, Inc. He is also the Chairman at Avanir Pharmaceuticals, Inc. and Otsuka America Pharmaceutical, Inc. Previously, he held various Chairman positions at Azelon Pharmaceuticals, Inc., Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Alvine Pharmaceuticals, Inc., REGENXBIO, Inc., Vitae Pharmaceuticals LLC, Transave, Inc., Insmed Ltd., Amicus Therapeutics, Inc., Cogentus Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Nora Therapeutics, Inc., and Dimension Therapeutics, Inc. He was also the Executive VP & President-Americas Region at Bristol Myers Squibb Co. and Vice President & GM-Mead Johnson Laboratories at Mead Johnson Nutrition Co. Additionally, he served as a Senior Advisor at Prospect Venture Partners.
He received his undergraduate degree from Harvard University and his MBA from Indiana University.

Cargos activos de Donald Hayden

EmpresasCargoInicio
Director Ejecutivo 25/04/2019
Presidente -

Antiguos cargos conocidos de Donald Hayden.

EmpresasCargoFin
THESEUS PHARMACEUTICALS, INC. Director/Miembro de la Junta 14/02/2024
REGENXBIO INC. Presidente 01/07/2020
INSMED INCORPORATED Presidente 08/11/2018
AMICUS THERAPEUTICS, INC. Presidente 08/02/2010
VITAE PHARMACEUTICALS INC Presidente 25/10/2016
Ver el detalle de la experiencia de Donald Hayden.

Formación de Donald Hayden.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

80

Relaciones de 1er grado

23

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology